GSK has voluntarily recalled one lot of Ventolin Diskus 200 μg salbutamol (albuterol) DPIs in Canada due to “a manufacturing issue that may result in a small number of Ventolin Diskus devices not delivering the full number of doses in the device,” the company said. The lot recalled is number 786G.
According to GSK, the root cause of the manufacturing issue has been corrected, and no adverse events linked to the problem were reported.
Ventolin HFA MDIs are not affected by the recall.
The company said, “We are committed to supplying high-quality products to Canadian patients and sincerely regret any inconvenience patients and healthcare professionals may experience related to this recall.”
Read the GSK statement.
